Thermo Fisher Scientific reported second-quarter 2026 results with revenue of $11.99B, net income of $1.74B and diluted EPS of $4.68, all up versus the prior-year quarter as the company cited strength across pharma/biotech, high-end instruments and efficiency gains.Financial Highlights¹ Reported as…
Explore more price target data and ratings for Thermo Fisher Scientific Inc on the Forecasts tab, and track all previous and future analyst recommendations for Thermo Fisher Scientific Inc in the dedicated News Flow.Select reference data provided by FactSet. Copyright © 2026 FactSet Research System…
Thermo Fisher Scientific reported second-quarter 2026 results with revenue of $11.99 billion and adjusted diluted EPS of $6.03. GAAP diluted EPS was $4.68 and net income attributable to the company was $1.736 billion for the quarter. Organic revenue growth was 5% year-over-year, with consolidated G…
Revenue grew 10% year-over-year to $11.99B in Q2 2026, with 5% organic growth and strong performance across all segments. Adjusted EPS rose 13% to $6.03, and the company repurchased $1.0B in stock while launching new products and expanding strategic collaborations.Original document: Thermo Fisher S…
TMO (Thermo Fisher Scientific Inc) is set to announce its Q2'26 results on July 23, before the market opens. The earnings are expected to be disclosed at 6:00 AM ET (10:00 AM UTC).For Q2'26, revenue estimate is 11.71 billion USD with EPS (earnings per share) anticipated at 5.72 USD. Learn more deta…
(17:14 GMT) Thermo Fisher Price Target Cut to $570.00/Share From $575.00 by Evercore ISI Group
